RxDoctor Payments Data

Kimberly Angelina, PA

Medical · Philadelphia, PANPI 1497222871

Payments from drug & device makers

$1,490in general payments, 2019–2025

Across 54 payments — averaging $27.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$349
  • Blueprint Medicines Corporation$177
  • CSL Behring$167
  • AstraZeneca$149
  • Regeneron Healthcare Solutions, Inc.$146
  • Biocryst US Sales Co., LLC$98
  • plus $405 from 9 others

What the payments were for

  • Food & beverage$1,38693%
  • Education$1057%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,490 in reported general payments places this provider in the 75th percentile of 2,594 medical providers in Pennsylvania.

See all medical providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$21,412
Medicare patients
140
Services billed
717

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate33$10,483
DuleraMometasone/Formoterol23$10,013
SymbicortBudesonide/Formoterol Fumarate17$8,028
Epinephrine25$5,852
Breo ElliptaFluticasone/Vilanterol11$5,379
Arnuity ElliptaFluticasone Furoate11$3,442
Mometasone Furoate23$3,418
Azelastine Hcl47$2,520
Olopatadine Hcl20$1,760
Albuterol Sulfate HfaAlbuterol Sulfate43$1,182
Ipratropium Bromide24$1,154
Fluticasone Propionate55$1,079
Montelukast Sodium44$821
Levocetirizine Dihydrochloride22$275
Famotidine12$171

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKBreo Ellipta, Arnuity Ellipta$77$8,82022 claims
AstraZenecaSymbicort$149$8,02817 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,594 medical providers in Pennsylvania.

Other medical in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →